Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Infect Control ; 52(3): 324-330, 2024 Mar.
Article in English | MEDLINE | ID: mdl-37741293

ABSTRACT

BACKGROUND: The purpose of this process and quality improvement activity was to address opportunities identified with cleaning, disinfection, and sterilization requirements for eye devices, and implement a robust and sustainable processing system to support safe patient care. METHODS: Through the lean 6 Sigma methodology, the evaluation of noncritical, semicritical and critical device processing was conducted. A hierarchal approach to law, regulation, manufacturer's instructions for use, evidence-based guidelines, consensus documents, facility risk assessments, policy, and procedure was conducted. Over 15 diverse clinical areas within a large health care network were assessed for utilization of ophthalmic and optometric devices, with the review of inventory for manufacturer-instructed cleaning, disinfection and sterilization compliance. RESULTS: An interdepartmental multidisciplinary team with oversight of over 10 service lines led the implementation of point-of-use treatment, transport, high-level disinfection, sterilization, storage, and documentation based on intended use. CONCLUSIONS: During this experience, infection Preventionists performed a vital role in supporting a highly reliable cleaning, disinfection, and sterilization process. This undertaking required a team approach to apply instructions for uses and evidence-based practice that promoted sustainability and ultimately led to supporting the prevention of health care-associated infections and patient harm.


Subject(s)
Cross Infection , Optical Illusions , Humans , Sterilization/methods , Disinfection/methods , Cross Infection/prevention & control , Health Facilities , Policy
2.
Liver Transpl ; 11(10): 1282-4, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16184556

ABSTRACT

Appendicitis among liver transplant recipients has not been described in the current literature. We report 8 recipients who experienced appendicitis three weeks to 181 months after liver transplantation (LT). Initial presenting findings differed from the nonimmunosuppressed population in that a majority of the patients did not have leukocytosis (>10,000 cells/mm3). Four patients experienced perforation, three of whom presented three days after the development of abdominal pain. All patients recovered after surgery without untoward sequela.


Subject(s)
Appendicitis/epidemiology , Liver Transplantation , Postoperative Complications/epidemiology , Abdominal Pain , Anti-Bacterial Agents/therapeutic use , Appendectomy , Appendicitis/complications , Appendicitis/surgery , Follow-Up Studies , Humans , Intestinal Perforation/etiology , Liver Transplantation/adverse effects , Retrospective Studies , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...